Does Trump Want to Lose the Midterms?

President Trump doesn’t seem to care that much about winning the midterms. He’s more unpopular at this point in his second term than basically any of his modern predecessors. Democrats seem poised to retake the House and have a real chance of retaking the Senate. You might expect a president in that position to pivot to the center, to focus on voters’ top concerns and try to boost the strongest Republicans in key races.

Trump isn’t doing any of that. Instead, he announced a $1.8 billion slush fund to pay out “victims of lawfare,” he threatened to re-escalate the Iran war, and he intervened in Republican primaries in ways that are gifts to Democrats, like endorsing the scandal-plagued Ken Paxton over the incumbent, John Cornyn, in Texas’ Senate race.

Why doesn’t Trump seem to care more about winning?

Liam Donovan is a Republican strategist and a president at Targeted Victory, a Washington public affairs and digital marketing firm. He has worked on the National Republican Senatorial Committee and for Cornyn. In this conversation, we discuss the moves Trump is making, the rough political environment for Republicans and what the paths to Democratic victories look like.

Mentioned:

“Graham Platner Thinks a Political Revolution Is Coming” by The Interview

Thomas Massie interview in The Washington Examiner

Book Recommendations:

The Right by Matthew Continetti

Apple in China by Patrick McGee

The Frackers by Gregory Zuckerman

Thoughts? Guest suggestions? Email us at ezrakleinshow@nytimes.com.

You can find transcripts (posted midday) and more episodes of “The Ezra Klein Show” at nytimes.com/ezra-klein-podcast, and you can find Ezra on Twitter @ezraklein. Book recommendations from all our guests are listed at https://www.nytimes.com/article/ezra-klein-show-book-recs.

This episode of “The Ezra Klein Show” was produced by Jack McCordick. Fact-checking by Michelle Harris with Julie Beer and Mary Marge Locker. Our senior engineer is Jeff Geld. Our recording engineer is Johnny Simon. Our executive producer is Claire Gordon. The show’s production team also includes Marie Cascione, Annie Galvin, Rollin Hu, Kristin Lin, Emma Kehlbeck, Marina King and Jan Kobal. Original music by Pat McCusker. Audience strategy by Shannon Busta. The director of New York Times Opinion Shows is Annie-Rose Strasser.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(507)

Yuval Noah Harari on Donald Trump’s Core Delusion

What are the conditions that enable a country to become great — or great again? The Trump administration — and other right-wing movements in other countries — offers a vision of greatness based on pow...

26 Maj 1h 53min

Is It Time to Break the Two-Party System?

We have entered a world of maximum gerrymandering warfare. Any guardrails that once existed, from the Constitution or the courts, have been bulldozed over the last decade – most recently in the Suprem...

19 Maj 1h 14min

This Is Why I Find Pema Chödrön So Essential

What do you do when you feel anxious or insecure? Many of us try to push the feeling away, or we ruminate on it, or try to solve it, or avoid the thought altogether. But what would happen if we did th...

15 Maj 1h 13min

I Have Some Questions for the Democrats Who Want to Run California

On Friday, I moderated a forum with the top Democratic candidates for California governor, focusing on the state’s housing crisis. California’s current governor, Gavin Newsom, came into office in 2019...

12 Maj 1h 32min

GLP-1s and the ‘Wild West’ of Wellness

Here’s a shocking number: One out of eight American adults is taking a GLP-1, like Ozempic or Zepbound, according to a KFF poll. GLP-1s are the biggest pharmaceutical story since antidepressants. But ...

8 Maj 1h 13min

The Book That Changed How I Think About Liberalism

In the U.S., illiberalism is in power. I don’t think anybody really argues against that. But I’ve been surprised by how weak liberalism has felt in response. Donald Trump isn’t a popular president; he...

5 Maj 1h 5min

What We Got Right — and Wrong — in ‘Abundance’

“Abundance” came out a little over a year ago. It’s been exciting — and a little disorienting — seeing how it’s rippled out into the world, and the ways it’s been embraced and debated and critiqued. S...

28 Apr 2h 3min